Image Credit: Microchips Biotech
Daré Bioscience, a clinical-stage biopharmaceutical company developing innovative products for women’s health, announced it entered into an agreement to acquire privately-held Microchips Biotech, Inc. Daré entered into the agreement to secure Microchips’ innovative, drug delivery technology, which it intends to evaluate as a programmable contraceptive.
Image Credit: MicroCHIPS
MicroCHIPS was founded in 1999 as an MIT spinoff to develop implantable sensors and drug-delivery devices.
MicroCHIPS’ drug-delivery technology is based on proprietary reservoir arrays that are used to store potent drugs within the body for long periods of time. Individual device reservoirs can be opened on demand or on a predetermined schedule to precisely control drug release or sensor activation. Continue reading